JPMorgan Chase & Co. Lowers Adient (NYSE:ADNT) Price Target to $37.00

Adient (NYSE:ADNTGet Free Report) had its price objective dropped by analysts at JPMorgan Chase & Co. from $40.00 to $37.00 in a report released on Monday, Benzinga reports. The firm presently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price objective points to a potential upside of 27.81% from the company’s current price.

A number of other equities research analysts have also recently commented on the company. Wells Fargo & Company decreased their price target on Adient from $41.00 to $40.00 and set an “overweight” rating for the company in a research note on Thursday, February 8th. Bank of America decreased their price target on Adient from $50.00 to $46.00 and set a “buy” rating for the company in a research note on Wednesday, April 10th. Finally, Barclays restated an “equal weight” rating and issued a $37.00 price objective (down from $41.00) on shares of Adient in a research note on Wednesday, April 10th. Two investment analysts have rated the stock with a sell rating, four have assigned a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $42.43.

Read Our Latest Stock Report on Adient

Adient Price Performance

Shares of ADNT stock opened at $28.95 on Monday. Adient has a 1-year low of $27.73 and a 1-year high of $46.51. The stock’s 50-day moving average is $32.57 and its 200 day moving average is $33.65. The company has a market cap of $2.64 billion, a P/E ratio of 12.92, a PEG ratio of 0.30 and a beta of 2.51. The company has a debt-to-equity ratio of 0.92, a current ratio of 1.15 and a quick ratio of 0.91.

Adient (NYSE:ADNTGet Free Report) last issued its quarterly earnings data on Wednesday, February 7th. The company reported $0.31 earnings per share for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.16). Adient had a net margin of 1.39% and a return on equity of 7.90%. The company had revenue of $3.70 billion for the quarter, compared to the consensus estimate of $3.76 billion. During the same period in the previous year, the business earned $0.34 EPS. Adient’s revenue for the quarter was up .0% compared to the same quarter last year. Research analysts predict that Adient will post 2.57 earnings per share for the current fiscal year.

Insider Buying and Selling at Adient

In other news, EVP Heather M. Tiltmann sold 10,000 shares of Adient stock in a transaction that occurred on Wednesday, February 14th. The stock was sold at an average price of $33.68, for a total value of $336,800.00. Following the sale, the executive vice president now directly owns 55,669 shares of the company’s stock, valued at $1,874,931.92. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.30% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Adient

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Executive Wealth Group LLC boosted its stake in Adient by 200.0% during the first quarter. Executive Wealth Group LLC now owns 108,642 shares of the company’s stock worth $3,678,000 after buying an additional 72,428 shares during the last quarter. First Hawaiian Bank boosted its stake in Adient by 21.1% during the first quarter. First Hawaiian Bank now owns 23,574 shares of the company’s stock worth $776,000 after buying an additional 4,100 shares during the period. Quadrature Capital Ltd boosted its stake in Adient by 46.8% during the fourth quarter. Quadrature Capital Ltd now owns 8,668 shares of the company’s stock worth $315,000 after buying an additional 2,764 shares during the period. Vanguard Group Inc. boosted its stake in Adient by 9.9% during the fourth quarter. Vanguard Group Inc. now owns 2,732,345 shares of the company’s stock worth $99,348,000 after buying an additional 246,038 shares during the period. Finally, Goldman Sachs Group Inc. boosted its stake in Adient by 1.5% during the fourth quarter. Goldman Sachs Group Inc. now owns 1,733,010 shares of the company’s stock worth $63,012,000 after buying an additional 25,534 shares during the period. Institutional investors and hedge funds own 92.44% of the company’s stock.

Adient Company Profile

(Get Free Report)

Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's automotive seating solutions include complete seating systems, frames, mechanisms, foams, head restraints, armrests, and trim covers.

Further Reading

Analyst Recommendations for Adient (NYSE:ADNT)

Receive News & Ratings for Adient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adient and related companies with MarketBeat.com's FREE daily email newsletter.